CAPTEM in Metastatic Well-Differentiated Intermediate to High Grade Neuroendocrine Tumors: A Single Centre Experience

INTRODUCTION: Capecitabine-temozolomide (CAPTEM) has significant activity in patients (pts) with metastatic low grade pancreatic neuroendocrine tumors (NETs). However, there is limited data regarding its activity in pts with metastatic well-differentiated intermediate and high grade pancreatic and n...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahu, Arvind, Jefford, Michael, Lai-Kwon, Julia, Thai, Alesha, Hicks, Rodney J., Michael, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402194/
https://www.ncbi.nlm.nih.gov/pubmed/30915122
http://dx.doi.org/10.1155/2019/9032753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6402194/
https://www.ncbi.nlm.nih.gov/pubmed/30915122
http://dx.doi.org/10.1155/2019/9032753

Ejemplares similares